Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.47
-0.01 (-0.15%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Bausch Health Companies stock have an average target of 7.20, with a low estimate of 3.00 and a high estimate of 10. The average target predicts an increase of 11.28% from the current stock price of 6.47.
Analyst Consensus: Hold
* Price targets were last updated on Feb 6, 2025.
Analyst Ratings
The average analyst rating for Bausch Health Companies stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $12 → $8 | Strong Buy → Hold | Downgrades | $12 → $8 | +23.65% | Feb 6, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +54.56% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +70.02% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $8.5 | Hold | Maintains | $10 → $8.5 | +31.38% | Aug 2, 2024 |
| Piper Sandler | Piper Sandler | Hold → Sell Downgrades $9 → $3 | Hold → Sell | Downgrades | $9 → $3 | -53.63% | Aug 2, 2024 |
Financial Forecast
Revenue This Year
10.08B
from 9.63B
Increased by 4.76%
Revenue Next Year
10.29B
from 10.08B
Increased by 2.05%
EPS This Year
4.69
from -0.13
EPS Next Year
4.92
from 4.69
Increased by 4.96%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5B | 10.9B | 11.3B | ||
| Avg | 10.1B | 10.3B | 10.6B | ||
| Low | 9.7B | 9.7B | 10.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.5% | 8.5% | 10.2% | ||
| Avg | 4.8% | 2.1% | 3.2% | ||
| Low | 1.1% | -3.9% | -2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.95 | 5.30 | 6.26 | ||
| Avg | 4.69 | 4.92 | 5.79 | ||
| Low | 4.52 | 4.49 | 5.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 12.9% | 27.1% | ||
| Avg | - | 5.0% | 17.5% | ||
| Low | - | -4.3% | 9.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.